Nephro Care India IPO Details

Bookbuilding IPO | ₹41 Cr | Listed at NSE SME | Fri, Jun 28, 2024 - Tue, Jul 2, 2024

Nephro Care IPO Logo

Nephro Care IPO is a book build issue of ₹41.26 crores. The issue is entirely a fresh issue of 0.46 crore shares of ₹41.26 crore.

Nephro Care IPO bidding started from Jun 28, 2024 and ended on Jul 2, 2024. The allotment for Nephro Care IPO was finalized on Jul 3, 2024. The shares got listed on NSE SME on Jul 5, 2024.

Nephro Care IPO price band is set at ₹90 per share. The lot size for an application is 1,600. The minimum amount of investment required by an retail is ₹1,44,000 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,88,000.

The issue includes a reservation of up to 2,25,600 shares for employees offered at a discount of ₹0.00 to the issue price.

Corporate Capitalventures Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is SS Corporate Securities Ltd..

Refer to Nephro Care IPO RHP for detailed Information.

IPO Open

Fri, Jun 28, 2024

IPO Close

Tue, Jul 2, 2024

Issue Price

₹90 per share

Market Cap (Pre-IPO)

₹148.38 Cr

IPO Details

IPO Date28 Jun to 2 Jul, 2024
Listed onFri, Jul 5, 2024
Face Value10 per share
Price Band₹85 to ₹90
Issue Price₹90 per share
Lot Size1,600 Shares
Sale TypeFresh capital only
Issue TypeBookbuilding IPO
Listing AtNSE SME

Total Issue Size45,84,000 shares
(agg. up to ₹41 Cr)
Reserved for Market Maker
2,30,400 shares
(agg. up to ₹2 Cr)
SS Corporate Securities Ltd.
Fresh Issue
(Ex Market Maker)
43,53,600 shares
(agg. up to ₹39 Cr)
Net Offered to Public43,53,600 shares
(agg. up to ₹39 Cr)
Share Holding Pre Issue1,19,02,400 shares
Share Holding Post Issue1,64,86,400 shares
NSE Symbol NEPHROCARE
ISININE0SUN01013

IPO Timetable

Issue Reservation

Nephro Care IPO comprises a total issue size of 45,84,000 shares. The net offer to the public is 41,28,000 shares, after excluding 2,30,400 shares allotted on a firm basis and 2,25,600 shares under a preferential allotment. Of the Net offer 20,64,000 (50.00%) are allocated to QIB, 6,19,200 (15.00%) allocated to NII 14,44,800 (35.00%) allocated to RII.

Investor Category Shares Offered % of Net Issue% of Total Issue
QIB Shares Offered 20,64,00050.00%45.03%
  − Anchor Investor Shares Offered 12,38,40027.02%
  − QIB (Ex. Anchor) Shares Offered 8,25,60018.01%
NII (HNI) Shares Offered 6,19,20015.00%13.51%
Retail Shares Offered 14,44,80035.00%31.52%
Preferential Reservations
Employee Shares Offered 2,25,6004.92%
Firm Reservations
Market Maker Shares Offered 2,30,4005.03%
Total Shares Offered 45,84,000100.00%100.00%

IPO Lot Size

Investors can bid for a minimum of 1,600 shares and in multiples thereof. 

Application Lots Shares Amount
Retail (Min) 1 1,600 ₹1,44,000
Retail (Max) 1 1,600 ₹1,44,000
HNI (Min) 2 3,200 ₹2,88,000
IPO Subscription Details

IPO Anchor Investors

Nephro Care IPO raises ₹11.15 crore from anchor investors. Nephro Care IPO Anchor bid date is June 27, 2024.
📝 Anchor Investors Letter (PDF)

Bid DateThu, Jun 27, 2024
Shares Offered12,38,400
Anchor Portion (₹ Cr.)11.15
Anchor lock-in period end date for 50% shares (30 Days)Fri, Aug 2, 2024
Anchor lock-in period end date for remaining shares (90 Days)Tue, Oct 1, 2024

Investor Category Reservations

Application CategoryMaximum Bidding LimitsBidding at Cut-off Price Allowed
Only RII Up to Rs 2 Lakhs Yes
Only NII Above Rs 2 Lakhs No
Only employee Yes
Employee + RII/NII
  • Employee limit: (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
  • If applying as RII: Upto Rs. 2 lakhs
  • If applying as NII: Above Rs. 2 lakhs
Yes for Employee and RII/NII

About Nephro Care India Ltd.

Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.

Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.

Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.

At present, Nephro Care offers the following services at its clinics:

  • In-house Dialysis Unit
  • Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology
  • NABL accredited inhouse Pathology
  • Inhouse Pharmacy
  • Advance diagnostic facilities
  • Renal Nutrition department
  • Home Care
  • Mukti (Lifestyle Support Program)
  • Home Dialysis

As of March 31, 2024 the hospital employs 110 people in various departments.

Company Financials (Restated)

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets20.308.314.631.13
Total Income19.9017.103.431.83
Profit After Tax3.401.94-0.010.09
NET Worth13.922.440.500.02
Reserves and Surplus13.331.94-0.000.01
Total Borrowing2.462.540.69
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 Setting up a Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal 26.15
2 General Corporate Expenses 10.03

Key Performance Indicator (KPI)

Pre IPOPost IPO
EPS (₹)1.632.75
P/E (x)55.1532.73
Promoter Holding85.02%61.39%
Market Cap148.38 Cr.
The company promoter is Dr. Pratim Sengupta.
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2023 available in RHP.

IPO Review

[Dilip Davda]
The company is engaged in providing healthcare services with renal insufficiency treatment. It marked inconsistency in its net earnings for the reported periods and the sudden surge in bottom in for 9M-FY24 raise eyebrows and concern over its sustainability going forward. Based on its super annualized FY24 earnings, the issue appears aggressively priced. There is no harm in skipping this pricey bet.
Read detail review...

Nephro Care IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers0001
Members1000

Nephro Care India IPO Subscription Status (Bidding Detail)

The Nephro Care India IPO is subscribed 715.78 times on July 2, 2024 6:19:55 PM (Day 3). The public issue subscribed 634.12 times in the retail category, 245.14 times in the QIB category, and 1,787.19 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)Shares OfferedShares bid for
QIB245.148,25,60020,23,87,200
NII*1,787.196,19,2001,10,66,25,600
Retail634.1214,44,80091,61,77,600
Total715.7831,15,2002,22,98,01,600

Total Application : 5,72,611

*Market Maker portion is not included to NII/HNI.

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 Issue Management Fees 0.50
2 Selling and Distribution Fees 2.06
3 Underwriting Commission 2.06
4 Advertising and marketing expenses 0.10
5 Fees payable to Registrar to the Issue 0.05
6 Brokerage and selling commission payable to SCSBs, Registered Brokers, RTAs and CDPs, as applicable 0.01
7 Processing fees to the SCSBs and to the Sponsor Banks for ASBA Forms procured by Registered Brokers, RTAs or CDPs 0.02
8 Printing and distribution of issue stationery 0.02
9 Listing fees 0.01
10 NSE Processing 0.00
11 Book Building software fees 0.04
12 Other regulatory expenses 0.10
13 Fees payable to legal counsel 0.01
14 Miscellaneous 0.10

Listing Day Trading Information

Price DetailsNSE SME
Final Issue Price90.00
Open171.00
Low171.00
High179.55
Last Trade179.55

Check IPO Performance…

IPO Registrar

Bigshare Services Pvt.Ltd.

Contact Details

Nephro Care India Ltd. Address
Flat No-1JC-18, 5th Floor Sec-III
Salt lake Kolkata, Bidhan Nagar Sai Complex,
North 24 Parganas
Kolkata, West Bengal, 700098
Open an Instant Account with Zerodha

IPO FAQs

Nephro Care IPO is a SME IPO of 45,84,000 equity shares of the face value of ₹10 aggregating up to ₹41 Crores. The issue is priced at ₹90 per share. The minimum order quantity is 1600.

The IPO opens on Fri, Jun 28, 2024, and closes on Tue, Jul 2, 2024.

Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Zerodha customers can apply online in Nephro Care IPO using UPI as a payment gateway. Zerodha customers can apply in Nephro Care IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Nephro Care IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Nephro Care IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Nephro Care IPO opens on Fri, Jun 28, 2024 and closes on Tue, Jul 2, 2024.

Nephro Care IPO lot size is 1600, and the minimum amount required for application is ₹1,44,000.

You can apply in Nephro Care IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Nephro Care IPO will be done on Wednesday, July 3, 2024, and the allotted shares will be credited to your demat account by Thu, Jul 4, 2024. Check the Nephro Care IPO allotment status.

The Nephro Care IPO listing date is on Fri, Jul 5, 2024.

Compare: